YIBO (YIBO) Stock Price & Analysis

YIBO (YIBO) fell 0.21% to USD 1.18 as of July 26, 2026 at 05:25 UTC, according to Nexqual real-time market data.

YIBO last closed at USD 1.18; the session ranged USD 1.17–1.18 on volume of 2,616 shares. Market capitalization is $69.93M, with a 52-week range of USD 0.63–1.82 (NCM). Source: Nexqual, July 26, 2026 at 05:25 UTC.

Key Statistics (as of July 26, 2026 at 05:25 UTC)

PriceUSD 1.18
Change▼ 0.21% (down)
Previous CloseUSD 1.18
OpenUSD 1.18
Day RangeUSD 1.17 – 1.18
52-Week RangeUSD 0.63 – 1.82
Volume2,616 shares
Market Cap$69.93M
ExchangeNCM

Technical Analysis (YIBO)

Nexqual's technical model rates YIBO "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 26, 2026 at 05:25 UTC.

Overall SignalSTRONG BUY
RSI (14)56.79 (neutral)
vs SMA50Above (USD 1.01)
MACD0.05 (positive)

Analyst Ratings (YIBO)

Wall Street analysts rate YIBO "None", per Nexqual as of July 26, 2026 at 05:25 UTC.

Consensus RatingNone

Earnings (YIBO)

Source: Nexqual, July 26, 2026 at 05:25 UTC.

Financials & Fundamentals (YIBO)

Total Revenue$155.25M
Revenue Growth (YoY)+11.30%
Gross Margin+29.43%
Operating Margin-0.99%
Profit Margin-5.32%
ROE-14.38%
Debt / Equity93.94
Current Ratio1.58
Total Cash$54.41M
Total Debt$54.40M
Free Cash Flow$-2.49M

Source: Nexqual, July 26, 2026 at 05:25 UTC.

Financial Health Score (YIBO)

Nexqual rates YIBO's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 05:25 UTC.

GrowthSolid — Revenue +11% YoY (latest Q)
ProfitabilityWeak — Gross margin 29%, operating -1%
Balance SheetMixed — $54M cash vs $54M debt, net cash position
Cash FlowWeak — FCF negative: -$2M, burning cash
EfficiencyCritical — ROE -14%, ROA -4.8%

Ownership (YIBO)

Insider Ownership+85.94%
Institutional Ownership+0.22%
Shares Outstanding32.92M
Float8.45M
Short % of Float+0.36%

Source: Nexqual, July 26, 2026 at 05:25 UTC.

Leadership (YIBO)

YIBO is led by Shaofang Weng (age 54), CEO & Director, per Nexqual as of July 26, 2026 at 05:25 UTC.

CEO & DirectorShaofang Weng (age 54)
Founder & Chairman of the BoardWeidong Gu (age 55)
Chief Financial OfficerQuanmao Zhou (age 35)

Peers & Related Stocks

SymbolNamePriceChange
SLXNSilexion Therapeutics CorpUSD 2.27▼ 9.92%
JDZGJIADE LIMITEDUSD 50▲ 0%
HWHHWH International Inc.USD 1.42▲ 13.6%
SUGPSU Group Holdings LimitedUSD 0.48▼ 8.56%
ATPCAgape ATP CorporationUSD 2.46▼ 2.77%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 05:25 UTC. This page is informational and not investment advice.